Skip to main content
SpringerLink
Log in

Dementia Screening and Surveillance

Are There Opportunities for Early Detection?

  • Review Article
  • Diagnosis
  • Published:
Disease Management and Health Outcomes

Abstract

The prevalence of dementia, and in particular Alzheimer’s disease, is expected to increase dramatically in the elderly population over the next few decades. Because of the possibilities of pharmacological and psychosocial interventions, which aim to slow down or even prevent progress of the disease, early detection of dementia is of the utmost importance. The screening of patients at risk is the first step in the detection of dementia and should be undertaken at the primary healthcare level. A history and mental state examination is necessary for all patients, and in particular for elderly patients, who have had cognitive complaints and/or reports of cognitive decline. Useful screening tests for dementia are either the Mini-Mental State Examination (MMSE) or the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE); an MMSE score <27 and an IQCODE score >3.31 indicate a possible dementia and should be further investigated. However, neither MMSE nor IQCODE should be used as a diagnostic tool.

Because of the heterogeneity of the deficits and the absence of a biological marker, the diagnosis of early degenerative dementias can be very complex and requires a multidisciplinary approach. Basic routine investigations carried out at the general practitioner (GP) level include physical and neurological examinations, a laboratory screen and a computerised tomography or magnetic resonance imaging examination. A neuropsychological examination is necessary to establish the diagnosis and there is promising evidence for the predictive value of some specific tests for Alzheimer’s disease. Complementary investigations such as functional neuroimaging, electroencephalogram and CSF investigations, may be indicated in some cases.

Efficient management programmes can only be effective if they are implemented as early as possible and adapted regularly to the changing needs of patients with dementia and their caregivers. The creation of health teams working in the community under the supervision of a GP seems to be a promising model for the care of the patient with dementia living in the community.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. DSM-IV. Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994 Jul.

  2. Evans DA, Funkenstein HH, Albert MS, et al. Prevalence of Alzheimers disease in a community population of older persons: higher than previously reported. JAMA. 1989; 262: 2551–6.

    Article  PubMed  CAS  Google Scholar 

  3. Melzer D. New drug treatment for Alzheimers disease: lessons for healthcare policy. BMJ. 1998; 316: 762–4.

    Article  PubMed  CAS  Google Scholar 

  4. Knopman DS, Schneider L, Davis K, et al. Long term tacrine (Cognex) treatment: effects on nursing home placement and mortality. Neurology. 1996; 47: 166–77.

    Article  PubMed  CAS  Google Scholar 

  5. Mayeux R, Foster NL, Rossor M, et al. Clinical evaluation of patients with dementia. In: Whitehouse PJ, editor. Dementia. Philadelphia: FA Davis, 1993: 92–130.

    Google Scholar 

  6. Levy R. Report: ageing-associated cognitive decline. Int Psychogeriatr. 1994; 6: 63–8.

    Article  PubMed  CAS  Google Scholar 

  7. Koivisto K, Reinikainen KJ, Hänninen T, et al. Prevalence of age-associated memory impairment in a randomly selected population from eastern Finland. Neurology. 1995; 45: 741–7.

    Article  PubMed  CAS  Google Scholar 

  8. Brayne C, Calloway P. Normal ageing, impaired cognitive function, and senile dementia of the Alzheimers type: a continuum? Lancet. 1988; I: 1265–7.

    Article  Google Scholar 

  9. Geldmacher DS, Whitehouse PJ. Differential diagnosis of Alzheimers disease. Neurology 1997; 48 Suppl. 6: S2–9.

    Article  PubMed  CAS  Google Scholar 

  10. Ham RJ, Sloane PD. Primary care geriatrics: a case based approach. 2nd ed. St Louis: Mosby Year Book, 1992.

    Google Scholar 

  11. Arnold SE, Kumar A. Reversible dementias. Med Clin North Am 1993 Jan; 77(1): 215–30.

    PubMed  CAS  Google Scholar 

  12. Cummings JL, Benson DF. Subcortical dementia: review of an emerging concept. Arch Neurol. 1984; 41: 874–9.

    Article  PubMed  CAS  Google Scholar 

  13. Whalley LJ. Definitions, clinical features and pathophysiology of Alzheimers disease. Clinician 1997 May; 15(1): 2–10.

    Google Scholar 

  14. Strittmatter WJ, Roses AD. Apolipoprotein E and Alzheimers disease. Proc Natl Acad Sci. 1993; 92: 4725–7.

    Article  Google Scholar 

  15. Corder E, Saunders A, Strittmatter WJ, et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimers disease in late onset families. Science. 1993; 261: 921–3.

    Article  PubMed  CAS  Google Scholar 

  16. National Institute on Ageing/Alzheimers Association Working Group. Apolipoprotein E genotyping in Alzheimers disease. Lancet. 1996; 347: 1091–5.

    Google Scholar 

  17. Miller BL. Clinical advances in degenerative dementias. Br J Psychiatry. 1997; 171: 1–3.

    Article  PubMed  CAS  Google Scholar 

  18. McKeith IG, Fairbairn AF, Bothwell RA, et al. An evaluation of the predictive validity and inter-rater reliability of clinical diagnostic criteria for senile dementia of the Lewy body type. Neurology. 1994; 44: 872–7.

    Article  PubMed  CAS  Google Scholar 

  19. Olafsdottir M, Marcusson J. Diagnosis of dementia at the primary care level. Acta Neurol Scand Suppl. 1996; 165: 58–62.

    Article  PubMed  CAS  Google Scholar 

  20. Marcusson J. Diagnosis of dementia at the GP level. News Dementia Issue. 1997; 3: 6–7.

    Google Scholar 

  21. Schmand B, Jonker C, Geerlings MI, et al. Subjective memory complaints in the elderly: depressive symptoms and future dementia. Br J Psychiatry. 1997; 171: 373–6.

    Article  PubMed  CAS  Google Scholar 

  22. Folstein M, Folstein S, McHugh PR. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 1975; 12: 189–98.

    Article  PubMed  CAS  Google Scholar 

  23. Tombaugh TN, McIntyre NJ. The Mini-Mental State Examination: a comprehensive review. J Am Geriatr Soc. 1992; 40: 922–35.

    PubMed  CAS  Google Scholar 

  24. Jorm Af, Jacomb PA. The Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE): socio-demographic correlates, reliability, validity and some norms. Psychol Med. 1989; 19: 1015–22.

    Article  PubMed  CAS  Google Scholar 

  25. Jorm AF, Broe GA, Creasey H, et al. Further data on the validity of the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE). Int J Geriatr Psychiatry. 1996; 2: 131–9.

    Article  Google Scholar 

  26. Mackinnon A, Mulligan R. Combining cognitive testing and informant report to increase accuracy in screening for dementia. Am J Psychiatry. In press.

  27. Becker JT, Boller F, Lopez OL, et al. The natural history of Alzheimer’s disease: description of study cohort and accuracy of diagnosis. Arch Neurol. 1994; 51: 585–94.

    Article  PubMed  CAS  Google Scholar 

  28. Albert MS. Cognitive and neurobiological markers of early Alzheimer’s disease. Proc Nat Acad Sci USA. 1996; 93: 13547–51.

    Article  PubMed  CAS  Google Scholar 

  29. Small BJ, Herlitz A, Fratiglioni L, et al. Cognitive predictors of incident Alzheimer’s disease: a prospective longitudinal study. Neuropsychology. 1997; 11: 413–20.

    Article  PubMed  CAS  Google Scholar 

  30. Buschke H, Sliwinski MJ, Kuslansky G, et al. Diagnosis of early dementia by the Double Memory Test: encoding specificity improves diagnostic sensitivity and specificity. Neurology. 1997; 48: 989–97.

    Article  PubMed  CAS  Google Scholar 

  31. Kaye MD, Swihart T, Howieson D, et al. Volume loss of the hippocampus and temporal lobe in healthy elderly persons destined to develop dementia. Neurology. 1997; 48: 1297–304.

    Article  PubMed  CAS  Google Scholar 

  32. Van der Linden M. Structure et fonctionnement de la mémoire. Actes des Journées Scientifiques de l’Ecole d’Orthophonie de Lyon sur le thème ‘Orthophonie et Neuropsychologie’. Lyon: Medcom, 1997: 5–12.

    Google Scholar 

  33. Tierney MC, Szalai JP, Snow WG, et al. Prediction of probable Alzheimer’s disease in memory-impaired patients: a prospective longitudinal study. Neurology. 1996; 46: 661–5.

    Article  PubMed  CAS  Google Scholar 

  34. Baddeley A. Working memory. New York: Oxford University Press, 1986.

    Google Scholar 

  35. Morris RG. Neurobiological correlates of cognitive dysfunction. In: Morris RG, editor. The cognitive neuropsychology of Alzheimer type dementia. Oxford: Oxford University Press, 1996: 223–54.

    Google Scholar 

  36. Brodaty H, Roberts K, Peters K. Quasi-experimental evaluation of an educational model for dementia caregivers. Int J Geriatr Psychiatry. 1994; 9: 195–204.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Memory Clinic, University Hospital of Geneva, 6, Rue du 31-Décembre, Geneva, CH-1207, Switzerland

    Reinhild Mulligan MD, FRCPsych (Director) & Anne-Claude Juillerat (Neuropsychologist)

  2. Department of Neuropsychology, University of Liège, Liège, Belgium

    Martial Van der Linden (Head)

Authors
  1. Reinhild Mulligan MD, FRCPsych
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Anne-Claude Juillerat
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Martial Van der Linden
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Reinhild Mulligan MD, FRCPsych.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Mulligan, R., Juillerat, AC. & Van der Linden, M. Dementia Screening and Surveillance. Dis-Manage-Health-Outcomes 3, 173–181 (1998). https://doi.org/10.2165/00115677-199803040-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-199803040-00002

Keywords

Search

Navigation